The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics ...

Following a filing revealing its intent to go public in the US on 6 January, artificial pancreas maker Beta Bionics has now ...

The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...

Technology & Telecommunication Acquisition Corp (NASDAQ:TETE), a special purpose acquisition company, has been notified of its pending delisting from the Nasdaq Stock Market due to non-compliance with ...

Apart from the public sale, the business intends to make a private placement of $17 million worth of shares to Wellington Hadley Harbor Aggregator IV, an 11% Beta Bonics equity holder. The conclusion ...

The stock markets today will eye Q3 results of 81 domestic companies, Flash manufacturing PMI, IPOs, FII selling, and Budget ...

The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...

Ascentage Pharma said on Thursday it aims to raise $126.4 million in an initial public offering in the United States, becoming the first sizeable Chinese firm to seek a listing in the U.S. this year.

When it comes to stock market debuts, 2024 was not an active year for many industries, not least cross-border payments, but ...

Private equity is looking at a better year with growth engines for investments, and better exits from lowered expectations, ...

The year 2025 is expected to see a resurgence of IPOs due to policy changes, monetary easing, and a favorable business ...

Hoth Therapeutics, Inc. (HOTH) a New York-based biopharmaceutical company, Friday announced that it has been notified by Nasdaq's ...